OFD1P9Y

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, OFD1P9Y RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated OFD1P9Y data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher OFD1P9Y RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OFD1P9Y expression acts as an unfavorable survival marker.

UCEC, BLCA, and COAD are the cancer types where OFD1P9Y RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
UCECOSTertileAll0.1980.873<.001108view →
BLCADFSTertileAll0.1580.627<.00199view →
COADDFSTertileAll0.1650.689.02072view →
STADOSTertileAll0.1730.583.01718view →
Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

OFD1P9Y–UCEC (OS)

Kaplan–Meier survival curve for OFD1P9Y RNA-high vs -low samples in UCEC.

Open the UCEC breakdown →

Exploration